Physician profile
Ryan Harris
NPI 1285228213
$5,279.82
in general payments reported to CMS, 2019-2025
23 companies · $765 in 2025
The $765 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $338 · 2022: $2,407 · 2023: $859 · 2024: $910 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,534.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,999.05 | 2022-2024 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,280.61 | 2021-2025 | Relistor, Trulance |
| Boston Scientific Corporation | $692.62 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Ibsa Pharma INC. | $302.04 | 2023-2025 | Tirosint, Licart, Flector |
| Abbvie INC. | $167.79 | 2022-2025 | |
| Biotronik Nro, INC. | $159.12 | 2023-2025 | Prospera, Biotronik |
| Vertos Medical, INC. | $101.10 | 2022-2023 | Mild Device Kit |
| Almatica Pharma LLC | $97.16 | 2021-2022 | |
| Amgen INC. | $91.47 | 2021-2022 | |
| Valinor Pharma, LLC | $69.92 | 2023-2024 | Movantik |
| Arbor Pharmaceuticals, INC. | $48.62 | 2021-2022 | |
| Spr Therapeutics, INC | $48.50 | 2022-2024 | Sprint Pns System |
| Medtronic, INC. | $38.59 | 2023 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $32.68 | 2025 | Ha Minuteman G3-R |
| Biohaven Pharmaceutical Holding Company LTD. | $27.99 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $18.26 | 2023 | Axonics |
| Fidia Pharma USA INC. | $17.17 | 2023 | Hymovis, Triluron |
| Painteq LLC | $16.88 | 2024 | Painteq |
| Pfizer INC. | $16.15 | 2023 | |
| Allergan, INC. | $14.97 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.54 | 2023 | Seglentis |
| Virtus Pharmaceuticals LLC | $12.96 | 2021 | |
| Collegium Pharmaceutical, INC. | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.